Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.

Chung A, Huynh K, Lawrence C, Sim MS, Giuliano A.

Ann Surg Oncol. 2012 Aug;19(8):2600-6. doi: 10.1245/s10434-012-2299-1. Epub 2012 Mar 7.

PMID:
22396004
2.

Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.

Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM.

Ann Surg Oncol. 2009 Oct;16(10):2697-704. doi: 10.1245/s10434-009-0641-z. Epub 2009 Aug 4.

PMID:
19653045
3.

Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.

Ashfaq A, McGhan LJ, Pockaj BA, Gray RJ, Bagaria SP, McLaughlin SA, Casey WJ 3rd, Rebecca AM, Kreymerman P, Wasif N.

Ann Surg Oncol. 2014 Sep;21(9):2934-40. doi: 10.1245/s10434-014-3712-8. Epub 2014 Apr 23.

PMID:
24756811
4.

Perceptions of contralateral breast cancer: an overestimation of risk.

Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T.

Ann Surg Oncol. 2011 Oct;18(11):3129-36. doi: 10.1245/s10434-011-1914-x. Epub 2011 Sep 27.

PMID:
21947590
5.

Contralateral prophylactic mastectomy in an Asian population: a single institution review.

Sim Y, Tan VK, Ho GH, Wong CY, Madhukumar P, Tan BK, Yong WS, Ng YY, Ong KW.

Breast. 2014 Feb;23(1):56-62. doi: 10.1016/j.breast.2013.10.008. Epub 2013 Nov 23.

PMID:
24275318
6.

Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution.

Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM.

Ann Surg Oncol. 2009 Oct;16(10):2691-6. doi: 10.1245/s10434-009-0547-9. Epub 2009 Jun 9.

PMID:
19506956
7.

Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.

Kuwajerwala NK, Dekhne NS, Pentiak PA, Fend D, Callahan RE, Amine M, Lucia V, Swartz J.

Clin Breast Cancer. 2013 Aug;13(4):287-91. doi: 10.1016/j.clbc.2013.02.006. Epub 2013 May 23.

PMID:
23706482
8.

Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients.

McGuire KP, Santillan AA, Kaur P, Meade T, Parbhoo J, Mathias M, Shamehdi C, Davis M, Ramos D, Cox CE.

Ann Surg Oncol. 2009 Oct;16(10):2682-90. doi: 10.1245/s10434-009-0635-x. Epub 2009 Aug 4.

PMID:
19653046
9.

Mastectomy and contralateral prophylactic mastectomy rates: an institutional review.

Damle S, Teal CB, Lenert JJ, Marshall EC, Pan Q, McSwain AP.

Ann Surg Oncol. 2011 May;18(5):1356-63. doi: 10.1245/s10434-010-1434-0. Epub 2010 Dec 2.

PMID:
21125335
10.

Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.

Pesce C, Liederbach E, Wang C, Lapin B, Winchester DJ, Yao K.

Ann Surg Oncol. 2014 Oct;21(10):3231-9. doi: 10.1245/s10434-014-3956-3. Epub 2014 Aug 1.

PMID:
25081341
11.

Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.

Elsayegh N, Kuerer HM, Lin H, Gutierrez Barrera AM, Jackson M, Muse KI, Litton JK, Albarracin C, Afrough A, Hortobagyi GN, Arun BK.

Ann Surg Oncol. 2014 Oct;21(11):3466-72. doi: 10.1245/s10434-014-3747-x. Epub 2014 May 6.

12.

The influence of preoperative MRI on breast cancer treatment.

Miller BT, Abbott AM, Tuttle TM.

Ann Surg Oncol. 2012 Feb;19(2):536-40. doi: 10.1245/s10434-011-1932-8. Epub 2011 Jul 13.

PMID:
21751044
13.

Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database.

Barry PN, Johnson RR, Harkenrider MM, Freeman AB, Kruse B, Wilson MR, Pan J, Dragun AE.

Am J Med Sci. 2012 Dec;344(6):452-6. doi: 10.1097/MAJ.0b013e31824a82ce.

PMID:
22395715
14.

Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.

Yao K, Stewart AK, Winchester DJ, Winchester DP.

Ann Surg Oncol. 2010 Oct;17(10):2554-62. doi: 10.1245/s10434-010-1091-3. Epub 2010 May 12.

PMID:
20461470
15.

Incremental risk associated with contralateral prophylactic mastectomy and the effect on adjuvant therapy.

Eck DL, Perdikis G, Rawal B, Bagaria S, McLaughlin SA.

Ann Surg Oncol. 2014 Oct;21(10):3297-303. doi: 10.1245/s10434-014-3903-3. Epub 2014 Jul 22.

PMID:
25047470
16.

Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies.

Mattos D, Gfrerer L, Ling IT, Reish RG, Hughes KS, Halpern EF, Cetrulo C, Colwell AS, Winograd JM, Yaremchuk MJ, Austen WG Jr, Liao EC.

Ann Surg Oncol. 2016 Mar;23(3):767-75. doi: 10.1245/s10434-015-4896-2. Epub 2015 Nov 17.

PMID:
26577123
17.

Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.

Soran A, Falk J, Bonaventura M, Keenan D, Ahrendt G, Johnson R.

Ann Surg Oncol. 2007 Feb;14(2):646-51. Epub 2006 Nov 23.

PMID:
17122987
18.

Locoregional recurrence after mastectomy with immediate transverse rectus abdominis myocutaneous (TRAM) flap reconstruction.

Patterson SG, Teller P, Iyengar R, Carlson GW, Gabram-Mendola SG, Losken A, Styblo T, Torres M, Wood WC, Perez SD, Mosunjac M, Rizzo M.

Ann Surg Oncol. 2012 Aug;19(8):2679-84. doi: 10.1245/s10434-012-2329-z. Epub 2012 Apr 3.

PMID:
22476750
19.

Issues of regret in women with contralateral prophylactic mastectomies.

Montgomery LL, Tran KN, Heelan MC, Van Zee KJ, Massie MJ, Payne DK, Borgen PI.

Ann Surg Oncol. 1999 Sep;6(6):546-52.

PMID:
10493622
20.

Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.

Pinell-White XA, Kolegraff K, Carlson GW.

Ann Plast Surg. 2014;72(6):S153-7. doi: 10.1097/SAP.0000000000000099.

PMID:
24691345

Supplemental Content

Support Center